EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study
暂无分享,去创建一个
M. Caruso | R. Polosa | P. Caponnetto | F. Cibella | D. Campagna | C. Russo | J. Morjaria
[1] Leon Kosmider,et al. Nicotine levels in electronic cigarettes. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[2] R. Polosa,et al. Handling relapse in smoking cessation: strategies and recommendations , 2013, Internal and Emergency Medicine.
[3] L. Dawkins,et al. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. , 2012, Addictive behaviors.
[4] P. Aveyard,et al. Weight gain in smokers after quitting cigarettes: meta-analysis , 2012, BMJ : British Medical Journal.
[5] Pasquale Caponnetto,et al. The emerging phenomenon of electronic cigarettes , 2012, Expert review of respiratory medicine.
[6] K. Fagerström. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[7] R. Polosa,et al. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series , 2011, Journal of medical case reports.
[8] J. Etter,et al. Saliva cotinine levels in users of electronic cigarettes , 2011, European Respiratory Journal.
[9] J. Etter,et al. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. , 2011, Addiction.
[10] Pasquale Caponnetto,et al. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study , 2011, BMC public health.
[11] R. Polosa,et al. Smoking Cessation with E-Cigarettes in Smokers with a Documented History of Depression and Recurring Relapses , 2011 .
[12] R. Polosa,et al. Effect of a nicotine-free inhalator as part of a smoking-cessation programme , 2011, European Respiratory Journal.
[13] M. Siegel,et al. Electronic cigarettes as a smoking-cessation: tool results from an online survey. , 2011, American journal of preventive medicine.
[14] Chris Bullen,et al. Electronic nicotine delivery systems: a research agenda , 2011, Tobacco Control.
[15] T. Nakao,et al. Safety Assessment of Electronic Cigarettes in Smokers , 2011 .
[16] M. Siegel,et al. Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes? , 2011, Journal of public health policy.
[17] T. Eissenberg,et al. A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[18] R. Polosa,et al. Therapeutic advances in the treatment of nicotine addiction: present and future , 2010, Therapeutic advances in chronic disease.
[19] Jean-François Etter,et al. Electronic cigarettes: a survey of users , 2010, BMC public health.
[20] H McRobbie,et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial , 2010, Tobacco Control.
[21] M. Fiore,et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. , 2009, Archives of internal medicine.
[22] Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update , 2008 .
[23] J. Hughes,et al. Effects of abstinence from tobacco: valid symptoms and time course. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[24] R. Anziano,et al. Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.
[25] Å. Westin,et al. Developmental history of the Glover-Nilsson smoking behavioral questionnaire. , 2005, American journal of health behavior.
[26] Karl Fagerstrom,et al. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.
[27] G. Burci. World Health Organization (WHO): Framework Convention on Tobacco Control* , 2003, International Legal Materials.
[28] Raydel Valdés Salgado. [The Framework Convention on Tobacco Control]. , 2003, Salud publica de Mexico.
[29] M. Fiore,et al. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. , 2002, Chest.
[30] M. Goolsby,et al. Treating Tobacco Use and Dependence , 2008, Pediatrics.
[31] K. Fagerström,et al. Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit , 2000, Tobacco control.
[32] Å. Westin,et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety , 2000, BMJ : British Medical Journal.
[33] K. Carroll,et al. Enhancing retention in clinical trials of psychosocial treatments: practical strategies. , 1997, NIDA research monograph.
[34] J. Samet. Health benefits of smoking cessation. , 1991, Clinics in chest medicine.
[35] R. Mulcahy. The health benefits of smoking cessation. , 1990, Irish medical journal.
[36] D. Hatsukami,et al. Effects of Abstinence from Tobacco , 1990 .
[37] A. Beck,et al. An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.
[38] P. Jacob,et al. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. , 1988, American journal of public health.
[39] N. Benowitz,et al. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. , 1981, Journal of chromatography.